Appointment booking for Dr. Charles Moylan, MD is currently not available.Dr. Charles Moylan, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charles Moylan, MD (he/him) is a Pediatrician in Kansas City, MO with over 18 years of experience. What is your opinion of Dr. Charles Moylan, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Moylan, MD has received over $3,641 which includes payments from the following companies:
$670.52 from Pfizer Inc.
$567.70 from Shire North American Group Inc
$227.19 from Cranial Technologies, Inc
$215.07 from Arbor Pharmaceuticals, Inc.
$214.23 from Teva Pharmaceuticals USA, Inc.
$184.67 from Sanofi Pasteur Inc.
$182.78 from Takeda Pharmaceuticals U.S.A., Inc.
$166.08 from Novum Pharma, LLC
$150.54 from GlaxoSmithKline, LLC.
$131.29 from Neos Therapeutics, LP
$113.61 from Merck Sharp & Dohme Corporation
$105.67 from Adlon Therapeutics L.P.
$78.96 from MedImmune, LLC
$76.40 from AstraZeneca Pharmaceuticals LP
$69.23 from Tris Pharma Inc
$67.58 from Ironshore Pharmaceuticals Inc.
$64.95 from Mylan Specialty L.P.
$54.51 from Sobi, Inc
$54.33 from Novo Nordisk Inc
$52.43 from sanofi-aventis U.S. LLC
Payments received by Dr. Charles Moylan, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!